CGP 74514 dihydrochloride

This compound is a potent and selective cdk1 inhibitor with an IC50 of 25 nM. In vitro studies in leukemia models show it reduces Akt phosphorylation and, when combined with LY294002, synergistically enhances mitochondrial damage, supporting its investigation in oncology research.